Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).

被引:0
作者
Escudier, Bernard J.
Iacovelli, Roberto
Lanoy, Emilie
Albiges, Laurence
Fizazi, Karim
机构
[1] Inst Gustave Roussy, Villejuif, France
[2] Univ Roma La Sapienza, Deparment Radiol Oncol & Human Pathol, Oncol Unit, I-00185 Rome, Italy
关键词
D O I
10.1200/jco.2012.30.5_suppl.397
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
397
引用
收藏
页数:1
相关论文
共 50 条
[41]   Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma [J].
Ilya V Tsimafeyeu ;
Lev V Demidov ;
Albina V Madzhuga ;
Oksana V Somonova ;
Anna L Yelizarova .
Journal of Experimental & Clinical Cancer Research, 28
[42]   Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma [J].
Tsimafeyeu V., I. ;
Madzhuga, A. ;
Demidov, L. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[43]   Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma [J].
Misbah, SA ;
Shaheen, PE ;
Elson, PJ ;
Negrier, S ;
Motzer, RJ ;
Andresen, SW ;
Bukowski, RM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :402S-402S
[44]   Increased expression of HMMR in renal cell carcinoma is an independent prognostic factor [J].
Zhang, Henglan ;
Li, Ling ;
Wang, Dongqing .
ONCOLOGY LETTERS, 2023, 25 (01)
[45]   EXCRETION OF PSEUDOURIDINE AS AN INDEPENDENT PROGNOSTIC FACTOR IN RENAL-CELL CARCINOMA [J].
RASMUSON, T ;
BJORK, GR ;
HIETALA, SO ;
STENLING, R ;
LJUNGBERG, B .
ACTA ONCOLOGICA, 1991, 30 (01) :11-15
[46]   Significance of anemia as an independent prognostic factor in patients with renal cell carcinoma [J].
Fernandez Gomez, Jesus Maria ;
Jalon Monzon, Antonio ;
Alvarez Mugica, Miguel ;
Garcia Rodriguez, Jorge ;
Miranda Aranzubia, Oscar ;
Gonzalez Alvarez, Roberto Carlos .
MEDICINA CLINICA, 2009, 133 (11) :407-413
[47]   VALUE OF MORPHOMETRY AS AN INDEPENDENT PROGNOSTIC FACTOR IN RENAL-CELL CARCINOMA [J].
RUIZ, JL ;
HERNANDEZ, M ;
MARTINEZ, J ;
VERA, C ;
JIMENEZCRUZ, JF .
EUROPEAN UROLOGY, 1995, 27 (01) :54-57
[48]   Gene expression profile of circulating tumor cells (CTCs) in clear cell metastatic renal cell carcinoma (mRCC) [J].
Iacovelli, R. ;
Nicolazzo, C. ;
Petracca, A. ;
Risi, E. ;
Cortesi, E. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
[49]   Early tumor shrinkage (eTS) - a novel endpoint for clinical studies in metastatic renal cell carcinoma (mRCC) [J].
Gruenwald, V. ;
Lin, X. ;
Kalanovic, D. ;
Simantov, R. .
EUROPEAN JOURNAL OF CANCER, 2015, 51 :S510-S511
[50]   Circulating tumor cells status in metastatic renal cell carcinoma (mRCC) after metastasectomy (RESORT trial) [J].
Verzoni, E. ;
Grassi, P. ;
Cappelleti, V. ;
Maggi, C. ;
Montone, R. ;
de Braud, F. ;
Procopio, G. .
ANNALS OF ONCOLOGY, 2015, 26 :63-63